Luis Pallardo
Overview
Explore the profile of Luis Pallardo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gorriz J, DMarco L, Pastor-Gonzalez A, Molina P, Gonzalez-Rico M, Puchades M, et al.
Nephrol Dial Transplant
. 2021 Jan;
37(3):522-530.
PMID: 33508124
Background: Hyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that...
2.
Cavero T, Arjona E, Soto K, Caravaca-Fontan F, Rabasco C, Bravo L, et al.
Kidney Int
. 2019 Aug;
96(4):995-1004.
PMID: 31420192
Malignant hypertension is listed among the causes of secondary thrombotic microangiopathy, but pathogenic mutations in complement genes have been reported in patients with hypertension-induced thrombotic microangiopathy. Here we investigated the...
3.
Milian L, Peris J, Gandia P, Andujar I, Pallardo L, Gorriz J, et al.
AIDS
. 2017 Jun;
31(12):1679-1684.
PMID: 28650379
Objective: In-vivo studies suggest that mitochondria is involved in tenofovir (TFV)-induced renal toxicity, but the underlying mechanisms are still unclear. The aim of the present study was to assess the...
4.
Avila A, Vizcaino B, Molina P, Gavela E, Perez-Ebri M, Pallardo L
Clin Kidney J
. 2015 Mar;
8(2):232-6.
PMID: 25815183
Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by haemolytic microangiopathic anaemia, thrombocytopaenia and acute onset of renal failure, in the absence of Escherichia coli infection. Renal damage...
5.
Campistol J, Carreno A, Morales J, Pallardo L, Franco A, Navarro D, et al.
Transplantation
. 2013 Jan;
95(2):e6-e10.
PMID: 23325012
No abstract available.
6.
Bernat Garcia J, Morales Suarez-Varela M, Vilata J, Marquina A, Pallardo L, Crespo J
Acta Derm Venereol
. 2013 Jan;
93(4):422-7.
PMID: 23303600
Non-melanoma skin cancer (NMSC) is the most frequent malignancy in organ transplant recipients. The aetiology of NMSC after transplant is multifactorial. The aim of this study was to determine the...
7.
Morales J, Marcen R, Del Castillo D, Andres A, Gonzalez-Molina M, Oppenheimer F, et al.
Nephrol Dial Transplant
. 2012 Dec;
27 Suppl 4:iv39-46.
PMID: 23258810
Background: To describe the causes of graft loss, patient death and survival figures in kidney transplant patients in Spain based on the recipient's age. Methods: The results at 5 years...
8.
Van Gurp E, Bustamante J, Franco A, Rostaing L, Becker T, Rondeau E, et al.
J Transplant
. 2010 Oct;
2010.
PMID: 20953372
In a multicenter trial, renal transplant recipients were randomized to tacrolimus with fixed-dose sirolimus (Tac/SRL, N = 318) or tacrolimus with MMF (Tac/MMF, N = 316). Targeted tacrolimus trough levels...
9.
Marcen R, Morales J, Fernandez-Rodriguez A, Capdevila L, Pallardo L, Plaza J, et al.
NDT Plus
. 2010 May;
3(Suppl_2):ii2-ii8.
PMID: 20508857
Background. Monitoring changes in glomerular filtration rate (GFR) is the recommended method for assessing the progression of kidney disease. The aim of this study was to assess the decline of...
10.
Pascual J, Del Castillo D, Cabello M, Pallardo L, Grinyo J, Fernandez A, et al.
Transplantation
. 2010 Mar;
89(8):994-1000.
PMID: 20335831
Background: Clinical data are lacking concerning therapeutic action and systemic exposure of tacrolimus (TAC) and everolimus (EVL) in a combined regimen in renal transplantation. Methods: A prospective randomized phase II...